Advertisement

Digitalis receptors affinity labelling and relation with positive inotropic and cardiotoxic effects

  • M. Lazdunski
  • T. Kazazoglou
  • J. F. Renaud
  • B. Rossi
Conference paper

Summary

Affinity labelling of the digitalis receptor has indicated that it is situated on the N-terminal part of the a-subunit of the (Na+,K+)ATPase.

Biochemical and pharmacological properties of the (Na+,K+)ATPase studied on intact chick embryonic hearts and under heart cell culture conditions have indicated the existence of two families of ouabain binding sites i.e.: a low affinity binding sites with a dissociation constant (Kd) of 2–6 μM for the ouabain- receptor complex and a high affinity binding site with a Kd of 26–48 nM. High and low affinity sites also are present at all embryonic stages studied. Inhibition of 86Rb+ uptake in cultured cardiac cells and increase in intracellular Na+ concentration, due to (Na+,K+)ATPase blockade, occur in an ouabain concentration range corresponding to the saturation of the low affinity ouabain site. Ouabain stimulated 45Ca2+ uptake increases in parallel with the increase in the intracellular Na+ concentration. It is suppressed in Na+ free medium or when Na+ is replaced by Li+ suggesting that the increase is due to the indirect activation of the Na+/Ca2+ exchange system in the plasma membrane. Dose-response curves for the inotropic effects of ouabain on papillary muscle and on ventricular cells in culture indicate the development of the cardiotonic properties is parallel to the saturation of the low affinity binding site for ouabain. Therefore, inhibition of the cardiac (Na+,K+) ATPase corresponding to low affinity ouabain binding sites seems to be responsible for both the cardiotonic and cardiotoxic effects of the drug.

Key words

Affinity labelling, digitalis receptor, heart, Na+/Ca2+ exchange system, inotropy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    KuD, Akera T, Pew CL, Brody TM (1974) Naunyn-Schmiedeberg’s Arch Pharmacol 285: 185 - 200CrossRefGoogle Scholar
  2. 2.
    Reuter H (1974) Circ Res 34: 599–605PubMedCrossRefGoogle Scholar
  3. 3.
    Schwartz A, Lindenmayer GE, Allen JC (1975) Pharmacol Rev 27: 3–134PubMedGoogle Scholar
  4. 4.
    Akera T, Brody TM (1977) Pharmacol Rev 29: 187–220PubMedGoogle Scholar
  5. 5.
    Gelbart A, Goldman RH (1977) Biochim Biophys Acta 481: 689–694PubMedCrossRefGoogle Scholar
  6. 6.
    Allen DG, Blinks JR (1978) Nature 273: 509–513PubMedCrossRefGoogle Scholar
  7. 7.
    Weingart R, Kass RS, Tsien RW (1978) Nature 273: 389–301PubMedCrossRefGoogle Scholar
  8. 8.
    Wood JM, Schwartz A (1978) J Mol Cell Cardiol 10: 137–144PubMedCrossRefGoogle Scholar
  9. 9.
    Biedert S, Barry WH, Smith TW (1979) J Gen Physiol 74: 479–494PubMedCrossRefGoogle Scholar
  10. 10.
    Noble D (1980) Cardiovas Res 14: 495–514CrossRefGoogle Scholar
  11. 11.
    Langer GA (1981) Biochem Pharmacol 30: 3261–3264PubMedCrossRefGoogle Scholar
  12. 12.
    Cohen CJ, Fozzard HA, Sheu SS (1982) Circ Res 50: 651–662PubMedCrossRefGoogle Scholar
  13. 13.
    Eisner DA, Lederer WJ (1982) Proc R Soc B 214:249–262Google Scholar
  14. 14.
    Sheu SS, Fozzard HA (1982) J Gen Physiol 80: 325–351PubMedCrossRefGoogle Scholar
  15. 15.
    Marban E, Tsien RW (1982) J Physiol 329: 589–614PubMedGoogle Scholar
  16. 16.
    Okita GT, Ten Eick RE, Richardson F (1974) Ann N Y Acad Sei 242: 658–670CrossRefGoogle Scholar
  17. 17.
    Godfraind T, Ghysel-Burton J (1977) Nature 265: 165–166PubMedCrossRefGoogle Scholar
  18. 18.
    Okita GT (1977) Fed Proc 36: 1115–2230Google Scholar
  19. 19.
    Michael L, Pitts BJR, Schwartz A (1978) Science 200: 1287–1289PubMedCrossRefGoogle Scholar
  20. 20.
    Godfraind T, Ghysel-Burton J (1980) Proc Natl Acad Sei 77: 3067–3069CrossRefGoogle Scholar
  21. 21.
    Rhee HM, Dutta S, Marks BH (1976) Eur J Pharmacol 37: 141–153PubMedCrossRefGoogle Scholar
  22. 22.
    Rhee HM, Huang WH, Askari A (1981) Eur J Pharmacol 70: 273–278PubMedCrossRefGoogle Scholar
  23. 23.
    Taniguchi K, Iida S (1972) Biophys Acta 288: 98–102Google Scholar
  24. 24.
    Inagaki C, Lindenmayer GE, Schwartz A (1974) J Biol Chem 249: 5135–5140PubMedGoogle Scholar
  25. 25.
    Hansen O (1976) Biochim Biophys Acta 433: 383–392CrossRefGoogle Scholar
  26. 26.
    Choi YR, Akera T (1977) Biochim Biophys Acta 481: 648–659PubMedCrossRefGoogle Scholar
  27. 27.
    Fricke U, Klaus W (1977) Br J Pharmacol 61: 423–428PubMedCrossRefGoogle Scholar
  28. 28.
    Van Alstyne E, Bartschat DK, Poe SL and Lindenmayer GE: Fed Proc 37: 779Google Scholar
  29. 29.
    De Pover A, Godfraind, T (1979) Biochem Pharmacol 28: 3051–3056PubMedCrossRefGoogle Scholar
  30. 30.
    Erdmann E, Philipp G, Scholz H (1980) Biochem Pharmacol 29: 3219–3229PubMedCrossRefGoogle Scholar
  31. 31.
    Wellsmith NY, Lindenmayer GE (1980) Circ Res 47: 710–720PubMedCrossRefGoogle Scholar
  32. 32.
    Adams RJ, Schwartz A, Grupp G, Grupp I, Lee SW, Wallick ET, Powell T, Twist VW, Gathiram P (1982) Nature 296: 167–169PubMedCrossRefGoogle Scholar
  33. 33.
    Mansier P, Lelievre LG (1983) Nature 300: 535–537CrossRefGoogle Scholar
  34. 34.
    Forbush B, Kaplan JH, Hoffman JF (1978) Biochemistry 17: 3667–3675PubMedCrossRefGoogle Scholar
  35. 35.
    Rogers TB, Lazdunski M (1979) Biochemistry 18: 135–140PubMedCrossRefGoogle Scholar
  36. 36.
    Rossi B, Vuillleumier P, Gache C, Baierna M, Lazdunski M (1980) J Biol Chem 255: 9936–9941PubMedGoogle Scholar
  37. 37.
    Goeldner MP, Hirth CG, Rossi B, Ponzio G, Lazdunski M (1983) Biochemistry 22: 4685–4690PubMedCrossRefGoogle Scholar
  38. 38.
    Castro J, Farley RA (1979) J Biol Chem 254: 2221–2228PubMedGoogle Scholar
  39. 39.
    Ponzio G, Rossi B, Lazdunski M (1983) J Biol Chem 258: 8799–8805Google Scholar
  40. 40.
    Kazazoglou T, Renaud JF, Rossi B, Lazdunski M (1983) J Biol Chem 258: 12163–12170PubMedGoogle Scholar
  41. 41.
    Renaud JF (1980) Biol Cell 37: 97–104Google Scholar
  42. 42.
    Fehlmann M, Morin O, Kitabgi P, Freychet P (1981) Endocrinology 109: 263–261CrossRefGoogle Scholar
  43. 43.
    Goshima K, Wakabayashi S (1981) J Mol Cell Cardiol 13: 489–509PubMedCrossRefGoogle Scholar
  44. 44.
    Blaustein MP (1974) Rev Physiol Biochem Pharmacol 70: 33–82PubMedCrossRefGoogle Scholar
  45. 45.
    Sulakhe PV, St Louis PJ (1980) In “Progress in Biophysics and Molecular Biology” 35: 135–195CrossRefGoogle Scholar
  46. 46.
    Wakabayashi S, Goshima K (1981) Biochim Biophys Acta 642: 158–172PubMedCrossRefGoogle Scholar
  47. 47.
    Reuter H, Seitz N (1968) J Physiol (Lond) 195: 451–470Google Scholar
  48. 48.
    Baker PF, Blaustein MP, Hodgkin AL, Steinhardt RA (1969) J Physiol (Lond) 200: 431–458Google Scholar
  49. 49.
    Ponce-Hornos JE, Langer GA (1980) J Mol Cell Cardiol 12: 1367–1382PubMedCrossRefGoogle Scholar
  50. 50.
    Fayet G, Couraud F, Miranda F, Lissitzky S (1974) Eur J Pharmacol 87: 165–174CrossRefGoogle Scholar
  51. 51.
    Bordes M, Bernengo JC, Renaud JF (1983) Rev Sei Intr 54: 1053–1058CrossRefGoogle Scholar
  52. 52.
    Crompton M, Capano M, Carafoli E (1976) Eur J Biochem 69: 453–462CrossRefGoogle Scholar
  53. 53.
    Carafoli E (1979) FEBS Lett 104: 1–5PubMedCrossRefGoogle Scholar
  54. 54.
    Werdan K, Krawietz W, Erdmann E (1983) J Mol Cell Cardiol 8:abstract p 15Google Scholar
  55. 55.
    Godfraind T, Noël F, Finet M (1983) J Mol Cell Cardiol 8:abstract p 43Google Scholar
  56. 56.
    Godfraind T, Ghysel-Burton J, De Pover A (1982) Nature 299: 824–826PubMedCrossRefGoogle Scholar
  57. 57.
    Forest C, Ponzio G, Rossi B, Lazdunski M, Ailhaud G (1982) Biochem Biophys Res Commun 107: 422–428PubMedCrossRefGoogle Scholar
  58. 58.
    Soderberg K, Rossi B, Lazdunski M, Louvard D (1983) J Biol Chem 258: 12300–12307.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • M. Lazdunski
    • 1
  • T. Kazazoglou
    • 1
  • J. F. Renaud
    • 1
  • B. Rossi
    • 1
  1. 1.Centre de Biochimie, Centre National de la Recherche Scientifique, Faculté des SciencesNice CedexFrance

Personalised recommendations